menu search

Nfl alumni health and paradigm anticipate touchdown for unmet osteoarthritis pain

NFL Alumni support ex-NFL players with medical symposium during NFL Draft Mount Laurel, NJ, June 27, 2023 (GLOBE NEWSWIRE) — In tandem with the NFL ...

June 27, 2023, 5:03 pm

Hip replacement implants market is likely to reach usd 7.0 bn by 2031 growing with cagr of 4.0%: tmr study

Significant rise in adoption of total hip arthroplasty (THA) procedures for end-stage degenerative hip osteoar...

May 11, 2023, 2:30 pm

Cult food science announces mou with jellatech to create collagen-enhanced pet foods

CULT Food Science Corp (CSE:CULT, OTCQB:CULTF) has announced a partnership with JellaTech, a company producing collagen through cellular agriculture,...

April 11, 2023, 8:03 am

Wellbeing digital sciences says kgk science subsidiary announces positive results from study on gj 191 supplement for osteoarthritis

Wellbeing Digital Sciences (NEO:MEDI.AQN, OTCQB:KONEF) Inc announced that a clinical study conducted by its wholly-owned subsidiary, KGK Science Inc, ...

June 16, 2022, 8:08 am

Ampio pharma shares fall as fda rejects proposed change in knee osteoarthritis trial

Ampio Pharmaceuticals Inc (NYSE: AMPE) received written responses from the FDA pursuant to a Type C meeting request regarding the AP-013 Phase 3 tria...

April 21, 2022, 6:29 am

Enveric biosciences advancing clinical plans as it announces two new molecules to treat osteoarthritis and other pain conditions

Enveric Biosciences (NASDAQ:ENVB) said that two new molecules, EV104a and EV104b, have been created to treat ...

February 8, 2022, 8:55 am

Enveric biosciences advancing clinical plans as it announces two new molecules to treat osteoarthritis and other pain conditions

Enveric Biosciences (NASDAQ:ENVB) said that two new molecules, EV104a and EV104b, have been created to treat ...

February 8, 2022, 8:55 am

Enveric biosciences advancing clinical plans as it announces two new molecules to treat osteoarthritis and other pain conditions

Enveric Biosciences (NASDAQ:ENVB) said that two new molecules, EV104a and EV104b, have been created to treat ...

February 8, 2022, 8:55 am

Enveric biosciences files provisional patent for cbd+celecoxib conjugate for osteoarthritis

Psychedelics-based neuroscience company Enveric Biosciences (NASDAQ: ENVB) announced the development of EV104a and EV104b, new molecular conjugates ...

February 8, 2022, 8:30 am

Enveric biosciences files provisional patent for cbd+celecoxib conjugate for osteoarthritis

Psychedelics-based neuroscience company Enveric Biosciences (NASDAQ: ENVB) announced the development of EV104a and EV104b, new molecular conjugates ...

February 8, 2022, 8:30 am

Enveric biosciences files provisional patent for cbd+celecoxib conjugate for osteoarthritis

Psychedelics-based neuroscience company Enveric Biosciences (NASDAQ: ENVB) announced the development of EV104a and EV104b, new molecular conjugates ...

February 8, 2022, 8:30 am


Search within

Pages Search Results: